Cardiovascular drug developer Sanifit raised $82.1m including $62.8m from investors that included existing backer Lundbeckfonden Ventures to bring its overall financing to $149m.

Spain-based vascular calcification medicine developer Sanifit closed a €55.2m ($62.8m) series D round on Wednesday featuring Lundbeckfonden Ventures, the corporate venturing arm of pharmaceutical firm Lundbeck.

The round was led by Caixa Capital Risc, the venture capital vehicle for financial services firm La Caixa, and also featured Columbus Venture Partners, Alta Life Sciences, Ysios Capital, HealthEquity, Forbion Capital Partners, Gilde Healthcare, Andera Partners and unnamed private investors.

The company claims the round is the largest ever to be raised by…